Back to search
FDAFDA · Food and drugs·Recall number D-0726-2022

Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, INDIA, NDC 55111-124-90

Published April 6, 2022 · Recall initiated: March 16, 2022

Summary

FDA records drug Class III recall D-0726-2022, published April 6, 2022 and initiated March 16, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 28,068 bottles; Lot: Lot: T000707, T000756, T000758, T000759, Exp 03/2022; T2100600, T2101075, Exp. 1/2023; T2102802, Exp. 07/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification results for related substance.

What to do

Voluntary: Firm initiated · Letter

Get an email if ATORVASTATIN CALCIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATORVASTATIN CALCIUM
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA.
Lot
Lot: T000707, T000756, T000758, T000759, Exp 03/2022; T2100600, T2101075, Exp. 1/2023; T2102802, Exp. 07/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, INDIA, NDC 55111-124-90 recalled?

Yes. FDA published recall D-0726-2022 on April 6, 2022. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification results for related substance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM.